PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2024 Earnings Call Transcript February 27, 2025
PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.24, expectations were $-1.12.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the PTC Therapeutics Fourth Quarter and Full Year 2024 Earnings Conference Call. All participants are in listen only mode. After the presentation, there will be a question-and-answer session. Today’s conference is being recorded. I...
